Three Treatment Methods via the Hepatic Artery for Hepatocellular Carcinoma - A Retrospective Study |
Ma, Teng-Chuang
(Department of Radiology, The First Hospital, China Medical University)
Shao, Hai-Bo (Department of Radiology, The First Hospital, China Medical University) Xu, Yang (Department of Radiology, The First Hospital, China Medical University) Xu, Ke (Department of Radiology, The First Hospital, China Medical University) |
1 | Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. Hepatol J, 35, 421-30. DOI ScienceOn |
2 | Camma C, Schepis F, Orlando A, et al (2002). Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology J, 224, 47-54. DOI ScienceOn |
3 | Farinati F, Giacomin A, Vanin V, et al (2012). TACE treatment in hepatocellular carcinoma: what should we do now. Hepatol J, 57, 221-2. DOI ScienceOn |
4 | Forner A, Llovet JM, Bruix J (2012). Chemoembolization for intermediate HCC: is there proof of survival benefit. Hepatol J, 56, 984-6. DOI ScienceOn |
5 | Geschwind JF, Ramsey DE, Choti MA, et al (1988). Chemoembolization of hepatocellular carcinoma: results of a metaanalysis. Clin Oncol AM J, 26, 344-9. |
6 | Ikoma A, Kawai N, Sato M, et al (2012). Comparison of blood dynamics of anticancer drugs (cisplatin, mitomycin C, epirubicin) in treatment groups of hepatic arterial infusion, hepatic arterial infusion with lipiodol and transcatheter arterial chemoembolization with lipiodol plus gelatin sponge particles in a swine model. Hepatol Res J, 42, 1227-35. DOI ScienceOn |
7 | Izumi R, Urade M, Kimura H, et al (1988). Combined hepatic arterial infusion chemotherapy with transcatheter arterial embolization and hyperthermia in primary liver cancer. Gan To Kagaku Ryoho, 15, 2465-9. |
8 | Lencioni R (2012). Chemoembolization for hepatocellular carcinoma. Semin Oncol J, 39, 503-9. DOI ScienceOn |
9 | Llovet JM, Bruix J (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology J, 37, 429-42. DOI ScienceOn |
10 | Marelli L, Stigliano R, Triantos C, et al (2007). Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol J, 30, 6-25. DOI ScienceOn |
11 | Miraglia R, Pietrosi G, Maruzzelli L, et al (2007). Efficacy of transcatheter emoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol J, 13, 2952-5. |
12 | Takayama W, Asano T, Kobayashi S, et al (1998). Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE). Gan To Kagaku Ryoho, 25, 867-71. |
13 | Morse MA, Hanks BA, Suhocki P, et al (2012). Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. Clin Colorectal Cancer J, 11, 185-90. DOI ScienceOn |
14 | Oliveri RS, Wetterslev J, Gluud C (2011). Transarterial (chemo) embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev, 16, CD004787. |
15 | Pleguezuelo M, Marelli L, Misseri M, et al (2008). TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther, 8, 1623-41. DOI ScienceOn |